-
Mashup Score: 0
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage future research.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0America Just Kinda, Sorta Banned Cigarettes - 28 day(s) ago
A new rule by the FDA could change smoking as we know it.
Source: www.theatlantic.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32
What molecular tests are needed in lung cancer? Which tumors need to be tested? How is the testing done? This video attempt to explain these and other questi…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Podcast: What Challenges Will Oncologists Face in 2025? - 2 month(s) ago
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact of Medicare drug price negotiations, ongoing drug shortages, and the promising role of AI and telehealth in improving patient outcomes and access to clinical trials.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Podcast: What Challenges Will Oncologists Face in 2025? - 2 month(s) ago
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact of Medicare drug price negotiations, ongoing drug shortages, and the promising role of AI and telehealth in improving patient outcomes and access to clinical trials.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer | JCO Oncology Practice - 3 month(s) ago
Until the early 2000s, advanced or metastatic non–small cell lung cancer (NSCLC) was treated as a single disease with all histologic subtypes treated alike with standard chemotherapy agents. Over the past two decades, the treatment paradigms for advanced …In this review, we discuss recent developments in the molecular profiling of non–small cell lung cancer (NSCLC), and approved and emerging targeted therapies for the treatment of NSCLC.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Expect Higher Costs for Your Health Care Benefits Next Year - 3 month(s) ago
Employers are predicting an increase of as much as 9 percent, on average, but are generally avoiding passing along much of that to their employees, industry groups say.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 09 tips for choosing a Medicare prescription drug plan - 3 month(s) ago
Medicare Part D is complex and can come with pitfalls — most significantly, plan terms and costs that may change every year.
Source: www.washingtonpost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Nate Pennell's fundraising page for VeloSano - 6 month(s) ago
100% for the cure! Riding for my mom and all my patients living with cancer.
Source: give.velosano.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Nate Pennell's fundraising page for VeloSano - 6 month(s) ago
100% for the cure! Riding for my mom and all my patients living with cancer.
Source: give.velosano.orgCategories: General Medicine News, Hem/OncsTweet
https://t.co/E7qep1A0Ey via @NYTimes